Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $165.9, a high estimate of $219.00, and a low estimate of $115.00. This current ...

A coffee variety called liberica, which is gaining popularity for the distinctive flavour of its beans, is actually three ...

Piper Sandler raised the firm’s price target on Biogen (BIIB) to $118 from $115 and keeps a Neutral rating on the shares. The ...

At the same time, more than half of the US-listed stocks covered by Morningstar that reported earnings as of Aug. 11 beat ...

Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease ...

The vitiligo treatment landscape is evolving with a shift towards targeted therapies, which have shown encouraging results in promoting repigmentatio ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Harrow's Q2 results show promise, but high debt, market challenges, and execution risks loom. Read here for strategies to ...

Spinal Muscular Atrophy (SMA) is a genetic disease that severely weakens muscles and causes developmental delays. It affects ...

The strongest rise in wholesale prices in three years limited upside for stocks on Thursday, with markets flatlining after ...

Controlling disease activity in systemic lupus erythematosus is one of many ways to prevent cardiovascular events in these ...

Major indices were in the red at the open on Thursday as investors digested last month's producer price index and weekly ...